Back to Search Start Over

Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease.

Authors :
Jiang, Jiehui
Wang, Min
Alberts, Ian
Sun, Xiaoming
Li, Taoran
Rominger, Axel
Zuo, Chuantao
Han, Ying
Shi, Kuangyu
Initiative, for the Alzheimer's Disease Neuroimaging
Source :
European Journal of Nuclear Medicine & Molecular Imaging; Jun2022, Vol. 49 Issue 7, p2163-2173, 11p, 1 Diagram, 3 Charts, 3 Graphs
Publication Year :
2022

Abstract

Background: Predicting the risk of disease progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) has important clinical significance. This study aimed to provide a personalized MCI-to-AD conversion prediction via radiomics-based predictive modelling (RPM) with multicenter 18F-fluorodeoxyglucose positron emission tomography (FDG PET) data. Method: FDG PET and neuropsychological data of 884 subjects were collected from Huashan Hospital, Xuanwu Hospital, and from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. First, 34,400 radiomic features were extracted from the 80 regions of interest (ROIs) for all PET images. These features were then concatenated for feature selection, and an RPM model was constructed and validated on the ADNI dataset. In addition, we used clinical data and the routine semiquantification index (standard uptake value ratio, SUVR) to establish clinical and SUVR Cox models for further comparison. FDG images from local hospitals were used to explore RPM performance in a separate cohort of individuals with healthy controls and different cognitive levels (a complete AD continuum). Finally, correlation analysis was conducted between the radiomic biomarkers and neuropsychological assessments. Results: The experimental results showed that the predictive performance of the RPM Cox model was better than that of other Cox models. In the validation dataset, Harrell's consistency coefficient of the RPM model was 0.703 ± 0.002, while those of the clinical and SUVR models were 0.632 ± 0.006 and 0.683 ± 0.009, respectively. Moreover, most crucial imaging biomarkers were significantly different at different cognitive stages and significantly correlated with cognitive disease severity. Conclusion: The preliminary results demonstrated that the developed RPM approach has the potential to monitor progression in high-risk populations with AD. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16197070
Volume :
49
Issue :
7
Database :
Complementary Index
Journal :
European Journal of Nuclear Medicine & Molecular Imaging
Publication Type :
Academic Journal
Accession number :
157024673
Full Text :
https://doi.org/10.1007/s00259-022-05687-y